In accordance with these results, activation of oncogenic KRAS and PI3K pathways and inactivation of tumor suppressor genes PTEN and ARID1A are suggested pathogenic mechanisms for clear-cell and endometrioid ovarian cancers [55, 56]. The gene discussed is PIK3CA; the disease is ovarian endometrioid adenocarcinoma.